Pittenger & Anderson Inc’s Halozyme HALO Stock Holding History

Pittenger & Anderson Inc’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-77	Closed	-$4.41K	–	447
2024 Q3	$4.41K	Buy	+77	New	+$4.41K	﹤0.01%	412

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pittenger & Anderson Inc's HALO Position: Q4 2024 in Review

Pittenger & Anderson Inc sold out of Halozyme (HALO) in Q4 2024, closing a stake of 77 shares — an estimated $4.41K sold.

Pittenger & Anderson Inc first reported a position in HALO in Q3 2024 and held it in 1 quarter. The position peaked at $4.41K in Q3 2024. 508 funds tracked by Wall St. Rank hold HALO as of Q4 2024.

Pittenger & Anderson Inc reported no remaining Halozyme position as of Q4 2024 after selling out during the quarter.
Pittenger & Anderson Inc sold 77 Halozyme shares in Q4 2024, an estimated $4.41K.
Pittenger & Anderson Inc first reported a position in Halozyme in Q3 2024 and held it in 1 quarter.
Pittenger & Anderson Inc's Halozyme position peaked at $4.41K in Q3 2024.
508 funds tracked by Wall St. Rank held Halozyme as of Q4 2024.

Based on Pittenger & Anderson Inc's 13F filing for Q4 2024, filed 31 Jan 2025.